Dr. Jia Wu's lab focuses on improving treatments for early-stage non-small cell lung cancer (NSCLC) using immunotherapy. They are researching how imaging can help identify patients who will benefit most from neoadjuvant immunotherapy before surgery. By developing new imaging biomarkers, the lab aims to enhance the effectiveness of cancer treatments and provide personalized medicine strategies for lung cancer patients.